REDDSTAR is an EU funded project which will develop and test stromal cell therapy to treat for diabetes mellitus. The objective is to control blood glucose while also addressing a range of diabetic complications.

 

Learn more about the project by visiting our patient publication section.

 

The REDDSTAR consortium is a network of diabetes specialists, regenerative medicine researchers, biotech industrialists and clinicians, supported by an experienced project management team.

 

REDDSTAR – Repair of  Diabetic Damage by Stromal Cell Administration

 

 

 Partners

Menu